The company develops residential and infrastructure real estate projects in Mumbai and recently diversified into the trading and manufacturing of industrial machinery.
The company lacks a durable competitive advantage, as evidenced by near-zero average returns on capital and a recent pivot into unrelated machinery trading to find stability. Financial metrics contradict any claim of a moat, with net margins below 1% and negative cash conversion.
Management has prioritized aggressive related-party lending and the acquisition of entities controlled by the same key personnel. Significant funds raised through preferential allotments have been funneled into unsecured loans to group entities rather than generating high returns for shareholders.
The collapse was driven by the inevitable evaporation of capital as the company functioned more as a clearinghouse for related-party interests than a productive enterprise. By funneling preferential allotment proceeds into unsecured loans for promoter-linked entities like Yogi Realtors, the firm effectively hollowed out its balance sheet. When the pivot into machinery trading failed to generate the necessary cash flow to cover the 1.31 debt-to-equity load, the lack of an independent auditor and the history of regulatory penalties culminated in a liquidity crisis, leaving shareholders with a shell of a business whose assets were tied up in unrecoverable group debts.
RichFakir rates Yogi Ltd's business quality as poor — 27/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Yogi Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Yogi Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Yogi Ltd's fair value is about ₹4 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →